Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections

Drugs. Jan-Feb 1982;23(1-2):1-36. doi: 10.2165/00003495-198223010-00001.
No abstract available

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Administration, Oral
  • Adult
  • Animals
  • Antifungal Agents / therapeutic use*
  • Blastomycosis / drug therapy
  • Candidiasis / drug therapy
  • Child, Preschool
  • Clinical Trials as Topic
  • Coccidioidomycosis / drug therapy
  • Cryptococcosis / drug therapy
  • Dermatomycoses / drug therapy
  • Dose-Response Relationship, Drug
  • Female
  • Fungi / drug effects
  • Guinea Pigs
  • Histoplasmosis / drug therapy
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / adverse effects
  • Imidazoles / blood
  • Imidazoles / therapeutic use*
  • Ketoconazole
  • Lethal Dose 50
  • Male
  • Mice
  • Mycoses / drug therapy*
  • Piperazines / administration & dosage
  • Piperazines / adverse effects
  • Piperazines / blood
  • Piperazines / therapeutic use*
  • Pregnancy
  • Reproduction / drug effects

Substances

  • Antifungal Agents
  • Imidazoles
  • Piperazines
  • Ketoconazole